Discover how selenium, exercise, and a single Brazil nut may boost neurogenesis, reduce oxidative stress, and protect against ...

Tucker Collins had to have his right eye surgically removed after a federal agent allegedly shot him in the head with a ...

'Romance Dawn,' the one-shot blueprint for Oda's magnum opus, expands the world of 'One Piece' as intriguingly as Netflix's live-action series—just in reverse. Reading time 5 minutes One Piece has ...

High Point’s Chase Johnston might be the most unlikely player in the entire NCAA tournament to produce a game-winning layup. Until the closing seconds of his team’s 83-82 first-round victory over ...

Samsung has started developing One UI 9, its next major interface update based on Android 17, with early internal builds already appearing on company servers. The first firmware build (BZC5) for the ...

A small aircraft crashed into Los Altos Golf Course while attempting to make an emergency landing Friday, leaving one person dead and another injured, authorities say. Albuquerque Fire Rescue was ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Choosing an exam prep ...

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.16%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...

Perplexity is abandoning advertising, for now at least. The company believes sponsored placements — even labeled ones — risk undermining the trust on which its AI answer engine depends. Why we care.

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...